- |||||||||| sirolimus / Generic mfg.
Trial primary completion date: Sirolimus and Familial Adenomatous Polyposis (FAP) (clinicaltrials.gov) - Jan 10, 2018 P2, N=5, Recruiting, Recruiting --> Completed Trial primary completion date: May 2018 --> Jan 2019
- |||||||||| sirolimus / Generic mfg.
Trial initiation date: Sirolimus and Familial Adenomatous Polyposis (FAP) (clinicaltrials.gov) - Jul 5, 2017 P2, N=5, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2012 --> Jun 2017 Initiation date: May 2017 --> Sep 2017
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: IPAA: Ileal Pouch-Anal Anastomosis Registry (clinicaltrials.gov) - Mar 17, 2017
P=N/A, N=936, Terminated, Initiation date: May 2017 --> Sep 2017 N=1500 --> 936 | Recruiting --> Terminated | Trial primary completion date: Dec 2050 --> Mar 2017; Researchers leading this study have left BMC
- |||||||||| Trial completion: Curcumin in Treating Patients With Familial Adenomatous Polyposis (clinicaltrials.gov) - Dec 14, 2016
P2, N=50, Completed, N=1500 --> 936 | Recruiting --> Terminated | Trial primary completion date: Dec 2050 --> Mar 2017; Researchers leading this study have left BMC Active, not recruiting --> Completed
- |||||||||| Trial termination, Trial primary completion date: NIPCON: Non-Invasive Prediction of Colorectal Neoplasia (clinicaltrials.gov) - Feb 9, 2015
P=N/A, N=2282, Terminated, N=140 --> 0 Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Nov 2015; Local PI did not submit annual renewal, still active in Detroit, not recruiting.
- |||||||||| sulindac / Generic mfg., erlotinib / Generic mfg.
Enrollment closed: FAPEST: A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients (clinicaltrials.gov) - Jun 23, 2014 P2, N=100, Active, not recruiting, Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Nov 2015; Local PI did not submit annual renewal, still active in Detroit, not recruiting. Recruiting --> Active, not recruiting
|